Public trading strategy
Eli Lilly's new weight-loss drug crushes expectations — ride the momentum
Created
Thesis
Weight-loss drugs are one of the hottest markets in healthcare right now. Eli Lilly's latest clinical trial impressed experts, proving their new drug works well. As doctors prescribe this medication to more patients, the company's profits are expected to surge. Getting in on this momentum early could capture the wave of excitement from doctors and investors alike.
Strategy approach
Build a momentum strategy for LLY on the 4-hour (H4) timeframe. Go long when the price breaks above the upper Bollinger Band (20, 2) and the MACD line crosses above the signal line. Use a 2% trailing stop to lock in gains.
Markets and timeframes
LLYH4
Entry and exit at a glance
These are the named rules in the shared configuration. Review the full conditions below before using a strategy.
- Entry: BB/MACD Crossover Long (LLY@4h) (3 conditions)
- Exit: TP: Near Resistance[2] (LLY@4h) (1 condition)
- Exit: SL: Fib Retracement 78.6% (LLY@4h) (1 condition)
Shared strategy rules
Rule configuration
{
"data_dependencies": [
{
"symbol": "LLY",
"timeframe": "4h"
}
],
"entry_rules": [
{
"conditions": [
{
"left": {
"field": "close",
"type": "price"
},
"operator": "crossed_above",
"right": {
"chart_ref": {
"symbol": "LLY",
"timeframe": "4h"
},
"field": "upper",
"indicator": {
"name": "bollinger_bands",
"period": 20,
"std_dev": 2
},
"type": "indicator"
}
},
{
"left": {
"chart_ref": {
"symbol": "LLY",
"timeframe": "4h"
},
"field": "line",
"indicator": {
"fast": 12,
"name": "macd",
"signal": 9,
"slow": 26
},
"type": "indicator"
},
"operator": "crossed_above",
"right": {
"chart_ref": {
"symbol": "LLY",
"timeframe": "4h"
},
"field": "signal",
"indicator": {
"fast": 12,
"name": "macd",
"signal": 9,
"slow": 26
},
"type": "indicator"
}
},
{
"left": {
"field": "close",
"type": "price"
},
"operator": "crossed_above",
"right": {
"rank": 1,
"type": "resistance_level"
}
}
],
"direction": "long",
"enabled": true,
"id": "entry_1",
"name": "BB/MACD Crossover Long (LLY@4h)",
"priority": 1,
"trade_symbol": "LLY"
}
],
"exit_rules": [
{
"applies_to": "both",
"conditions": [
{
"left": {
"field": "close",
"type": "price"
},
"operator": "greater_than_or_equal",
"right": {
"rank": 2,
"type": "resistance_level"
}
}
],
"enabled": true,
"id": "exit_1",
"name": "TP: Near Resistance[2] (LLY@4h)",
"priority": 97,
"purpose": "take_profit",
"target_symbol": "LLY"
},
{
"applies_to": "both",
"conditions": [
{
"left": {
"field": "close",
"type": "price"
},
"operator": "less_than",
"right": {
"chart_ref": {
"symbol": "LLY",
"timeframe": "4h"
},
"ratio": 786,
"type": "fibonacci_retracement"
}
}
],
"enabled": true,
"id": "exit_2",
"name": "SL: Fib Retracement 78.6% (LLY@4h)",
"priority": 100,
"purpose": "stop_loss",
"target_symbol": "LLY"
}
],
"position_sizing": {
"max_position_percent": 25,
"method": {
"fib_stop_ratio": 786,
"risk_percent": 2,
"type": "fixed_risk"
},
"min_position_value": 100
},
"trigger_timeframe": "4h",
"version": 1
}Indicator configuration
{
"indicators": [
{
"name": "bollinger_bands",
"period": 20,
"std_dev": 2
},
{
"fast": 12,
"name": "macd",
"signal": 9,
"slow": 26
}
]
}Parsed strategy
{
"data_dependencies": [
{
"symbol": "LLY",
"timeframe": "4h"
}
],
"entry_rules": [
{
"conditions": [
{
"left": {
"field": "close",
"type": "price"
},
"operator": "crossed_above",
"right": {
"chart_ref": {
"symbol": "LLY",
"timeframe": "4h"
},
"field": "upper",
"indicator": {
"name": "bollinger_bands",
"period": 20,
"std_dev": 2
},
"type": "indicator"
}
},
{
"left": {
"chart_ref": {
"symbol": "LLY",
"timeframe": "4h"
},
"field": "line",
"indicator": {
"fast": 12,
"name": "macd",
"signal": 9,
"slow": 26
},
"type": "indicator"
},
"operator": "crossed_above",
"right": {
"chart_ref": {
"symbol": "LLY",
"timeframe": "4h"
},
"field": "signal",
"indicator": {
"fast": 12,
"name": "macd",
"signal": 9,
"slow": 26
},
"type": "indicator"
}
},
{
"left": {
"field": "close",
"type": "price"
},
"operator": "crossed_above",
"right": {
"rank": 1,
"type": "resistance_level"
}
}
],
"direction": "long",
"enabled": true,
"id": "entry_1",
"name": "BB/MACD Crossover Long (LLY@4h)",
"priority": 1,
"trade_symbol": "LLY"
}
],
"exit_rules": [
{
"applies_to": "both",
"conditions": [
{
"left": {
"field": "close",
"type": "price"
},
"operator": "greater_than_or_equal",
"right": {
"rank": 2,
"type": "resistance_level"
}
}
],
"enabled": true,
"id": "exit_1",
"name": "TP: Near Resistance[2] (LLY@4h)",
"priority": 97,
"purpose": "take_profit",
"target_symbol": "LLY"
},
{
"applies_to": "both",
"conditions": [
{
"left": {
"field": "close",
"type": "price"
},
"operator": "less_than",
"right": {
"chart_ref": {
"symbol": "LLY",
"timeframe": "4h"
},
"ratio": 786,
"type": "fibonacci_retracement"
}
}
],
"enabled": true,
"id": "exit_2",
"name": "SL: Fib Retracement 78.6% (LLY@4h)",
"priority": 100,
"purpose": "stop_loss",
"target_symbol": "LLY"
}
],
"position_sizing": {
"max_position_percent": 25,
"method": {
"fib_stop_ratio": 786,
"risk_percent": 2,
"type": "fixed_risk"
},
"min_position_value": 100
},
"trigger_timeframe": "4h",
"version": 1
}Strategy instructions
Trading agent generated from recommendation idea 'Eli Lilly's new weight-loss drug crushes expectations — ride the momentum'. Thesis: Weight-loss drugs are one of the hottest markets in healthcare right now. Eli Lilly's latest clinical trial impressed experts, proving their new drug works well. As doctors prescribe this medication to more patients, the company's profits are expected to surge. Getting in on this momentum early could capture the wave of excitement from doctors and investors alike.
Performance
No trade count, win rate, or realized P&L figures are provided in this public preview. The thesis and shared rules do not establish a performance record.
What this public preview can establish
- The thesis and strategy approach describe a market view. They do not show whether an entry or exit condition is currently met.
- Technical strategy fields are shared above. Inspect the actual conditions and check when they were evaluated before relying on them.
- No trade count, win rate, or P&L figure is published in this preview. It cannot establish a performance record.
Explore
How CommonQuant researches and tests strategies · Public paper-trading record and its limits · Discover public strategies